Hospital push could shield seniors from preventable diseases
NCT ID NCT03587610
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This trial evaluates whether a hospital-based remedial vaccination strategy can improve Tdap-IPV (tetanus, diphtheria, pertussis, polio) vaccination rates in adults aged 65 and older in the Sarthe region of France. Participants are randomly assigned to receive either the remedial strategy or standard care, and the study measures changes in immunization coverage. The goal is to find an effective way to protect older adults from these serious infections.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Tdap-IPV vaccine (tetanus, diphtheria, pertussis, polio)
- What this could lead to
- If successful, this approach could help increase vaccination coverage among older adults, reducing the risk of preventable diseases in this age group.
- What could go wrong
- The study is small and focused on one region in France, so results may not apply elsewhere. It tests a process, not a new vaccine, so the impact depends on how well hospitals adopt the strategy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VACCINATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Hospitalier Le Mans
Le Mans, 72 000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Meningitis b vaccine shows promise in children
- Teens' sleep habits may boost vaccine power
- Simple exercise test may reveal hidden risks in flu patients
- Nutrient sachets may boost vaccination rates in rural africa
- Text reminders help get young kids vaccinated on time
- Mpox vaccine trial for infants: could a Half-Dose protect just as well?